Home/Cinclus Pharma/Kjell Andersson

KA

Kjell Andersson

Co-founder, Chief Scientific Officer, Board Member

Therapeutic Areas

Gastroenterology Infectious Disease

Cinclus Pharma Pipeline

Drug	Indication	Phase
Linaprazan Glurate	Severe Gastroesophageal Reflux Disease (GERD)	Phase 2

Leadership Team at Cinclus Pharma

Christer Ahlberg

Chief Executive Officer

Magnus Christensen

Chief Financial Officer

View full Cinclus Pharma profile